GlaxoSmithKline PLCAdd to My Watchlist

GSK:USNew YorkIndustry: Medical-Drugs
  • 41.34
    Last
  • 0.42  1.03%
    Today's Change
  • 40.92
    Previous Close
  • Today
     
    37.20
    45.58
    52 Week Low - High
8:04 pm ET 2/17/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding2 billion
Market Cap$101 billion
Return on Equity ttm29.24%
Last Dividend$0.57
Dividend Yield ttm5.04
Relative Dividend Yield benchmark--
Dividend Ex-Date2/22/17
Dividend Pay Date4/13/17
Earnings
EPS: Year Actual ttm--
EPS: Year Est. 12/17 ttm2.234
 
EPS: Quarterly Actual 12/16 --
EPS: Quarterly Est. 3/17 0.52
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-89.21
Company Description
GlaxoSmithKline plc is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
Revenue$28 billion
Net Income$912 million
Total Assets$59 billion
Employees101,192
Web Sitewww.gsk.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!